Important Updates for MacroGenics, Inc. Investors
Attention, shareholders of MacroGenics, Inc. (NASDAQ: MGNX). If you've experienced financial losses related to your investments in this company, there are crucial updates and opportunities you should consider.
Overview of the Class Action
Investors who acquired shares of MGNX during the designated class period are encouraged to reach out to a law firm that specializes in class actions. While it’s not necessary to be appointed as the lead plaintiff to recover losses, participating in this legal process may prove advantageous.
Class Period Details
The class period for this action runs from March 7, 2024, to May 9, 2024. During this timeframe, serious concerns arose regarding the safety data from the TAMARACK Phase 2 study of the drug vobramitamab duocarmazine. On May 9, 2024, alarming information about the drug’s safety was revealed, resulting in a significant decline in MGNX's stock price, which plummeted by 77.4% or $11.36 per share.
Crucial Deadlines
Shareholders must act quickly, as the deadline to register for this class action is September 24, 2024. It’s vital to register in order to secure your status as a shareholder during this period.
Your Next Steps as a Shareholder
Once you register, participants will gain access to portfolio monitoring software that offers ongoing updates about the case. This is an effective way to stay informed about developments as the legal action progresses.
Why Choose The Gross Law Firm?
The Gross Law Firm is committed to protecting the interests of investors. The firm diligently works to hold companies accountable for any fraudulent activities or misleading communications that could adversely affect stock value. Their goal is to help recover losses incurred by shareholders due to damaging misinformation.
Contact Information for Investors
If you need further clarification or wish to initiate a claim, you can contact The Gross Law Firm:
Address:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Phone: (646) 453-8903
Frequently Asked Questions
What is the purpose of the class action?
The class action aims to assist shareholders in recovering losses caused by misleading information regarding MacroGenics, Inc.
How do I know if I'm eligible to join the class action?
If you purchased shares of MacroGenics between March 7, 2024, and May 9, 2024, you may qualify to participate.
What happens after I register?
After registration, you will receive updates and be monitored throughout the litigation process until it concludes.
Is there any cost to join the class action?
No, there are no costs or obligations to participate in this case.
Who will represent the shareholders?
The Gross Law Firm will represent the class action, utilizing their expertise and commitment to investor protection.